These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1945204)

  • 1. Risk factors for gestational trophoblastic disease: a separate analysis of complete and partial hydatidiform moles.
    Parazzini F; Mangili G; La Vecchia C; Negri E; Bocciolone L; Fasoli M
    Obstet Gynecol; 1991 Dec; 78(6):1039-45. PubMed ID: 1945204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
    Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
    BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of women with recurrent molar pregnancies.
    Lorigan PC; Sharma S; Bright N; Coleman RE; Hancock BW
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):288-92. PubMed ID: 10985882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal age-related rates of gestational trophoblastic disease.
    Altman AD; Bentley B; Murray S; Bentley JR
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):244-50. PubMed ID: 18669718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
    Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
    Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational trophoblastic disease in the Asian population of Northern England and North Wales.
    Tham BW; Everard JE; Tidy JA; Drew D; Hancock BW
    BJOG; 2003 Jun; 110(6):555-9. PubMed ID: 12798471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysis.
    Jeffers MD; O'Dwyer P; Curran B; Leader M; Gillan JE
    Int J Gynecol Pathol; 1993 Oct; 12(4):315-23. PubMed ID: 8253548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gestational trophoblastic diseases. Classification, epidemiology and genetic data].
    Dreyfus M; Tissier I; Philippe E
    J Gynecol Obstet Biol Reprod (Paris); 2000 Apr; 29(2):125-30. PubMed ID: 10790623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive use and gestational choriocarcinoma.
    Palmer JR
    Cancer Detect Prev; 1991; 15(1):45-8. PubMed ID: 2044074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance.
    Genest DR; Laborde O; Berkowitz RS; Goldstein DP; Bernstein MR; Lage J
    Obstet Gynecol; 1991 Sep; 78(3 Pt 1):402-9. PubMed ID: 1876374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydatidiform molar pregnancy in Malaysian women: a histopathological study from the University Hospital, Kuala Lumpur.
    Cheah PL; Looi LM; Sivanesaratnam V
    Malays J Pathol; 1993 Jun; 15(1):59-63. PubMed ID: 8277792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome after hydatidiform mole, initial and recurrent.
    Yapar EG; Ayhan A; Ergeneli MH
    J Reprod Med; 1994 Apr; 39(4):297-9. PubMed ID: 8040847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
    Osamor JO; Oluwasola AO; Adewole IF
    J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gestational trophoblastic tumors and recent clinical information].
    Shimizu T; Yaegashi N
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational trophoblastic disease among Hispanic women: a 21-year hospital-based study.
    Drake RD; Rao GG; McIntire DD; Miller DS; Schorge JO
    Gynecol Oncol; 2006 Oct; 103(1):81-6. PubMed ID: 16516953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic features of hydatidiform mole in the Netherlands.
    Franke HR; Risse EK; Kenemans P; Vooijs GP; Stolk JG
    Obstet Gynecol; 1983 Nov; 62(5):613-6. PubMed ID: 6621952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic and immunohistochemical evaluation of blood vessels in complete and partial hydatidiform mole.
    Dickson-González SM; García de Barriola V; Barbella-Aponte RA; Figueira L; Cortés-Charry R; Naranjo de Gómez M
    J Reprod Med; 2006 Dec; 51(12):933-7. PubMed ID: 17253040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.